Table 1 Distribution of study participants
From: RCC-Supporter: supporting renal cell carcinoma treatment decision-making using machine learning
Group1 (Surveillance) | Group2 (Surgery) | Group3 (Chemotherapy) | Total | |
|---|---|---|---|---|
Number of participants | 748 (40%) | 893 (48%) | 226 (12%) | 1867 (100%) |
Gender | ||||
Male | 432 (58%) | 590 (66%) | 163 (72%) | 1185 (63%) |
Female | 316 (42%) | 303 (34%) | 63 (28%) | 682 (37%) |
Age (years) | 57.36 ± 13.56 | 60.75 ± 12.90 | 64.37 ± 12.15 | |